{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:56:39Z","timestamp":1790621799829,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiol med"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s11547-015-0562-9","type":"journal-article","created":{"date-parts":[[2015,6,30]],"date-time":"2015-06-30T10:17:43Z","timestamp":1435659463000},"page":"54-59","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Anal cancer FDG-PET standard uptake value: correlation with tumor characteristics, treatment response and survival"],"prefix":"10.1007","volume":"121","author":[{"given":"Letizia","family":"Deantonio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Elisa","family":"Milia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Cena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianmauro","family":"Sacchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carola","family":"Perotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Brambilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Turri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Krengli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,1]]},"reference":[{"key":"562_CR1","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.ejso.2014.07.030","volume":"40","author":"R Glynne-Jones","year":"2014","unstructured":"Glynne-Jones R, Nilsson PJ, Aschele C et al (2014) Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Eur J Surg Oncol 40:1165\u20131176","journal-title":"Eur J Surg Oncol"},{"key":"562_CR2","first-page":"513","volume":"29","author":"V Martin","year":"2014","unstructured":"Martin V, Zanellato E, Franzetti-Pellanda A et al (2014) EGFR, KRAS, BRAF, and PIK3CA characterization in squamous cell anal cancer. Histol Histopathol 29:513\u2013521","journal-title":"Histol Histopathol"},{"key":"562_CR3","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/BF02586980","volume":"17","author":"ND Nigro","year":"1974","unstructured":"Nigro ND, Vaitkevicius VK, Considine B (1974) Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 17:354\u2013356","journal-title":"Dis Colon Rectum"},{"key":"562_CR4","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(96)03409-5","volume":"348","author":"UKCCCR Anal Cancer Trial Working UK Party Co-ordinating Committee on Cancer Research","year":"1996","unstructured":"UKCCCR Anal Cancer Trial Working UK Party Co-ordinating Committee on Cancer Research (1996) Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. Lancet 348:1049\u20131054","journal-title":"Lancet"},{"key":"562_CR5","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1200\/JCO.1997.15.5.2040","volume":"15","author":"H Bartelink","year":"1997","unstructured":"Bartelink H, Roelofsen F, Eschwege F et al (1997) Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European organization for research and treatment of cancer radiotherapy and gastrointestinal cooperative groups. J Clin Oncol 15:2040\u20132049","journal-title":"J Clin Oncol"},{"key":"562_CR6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0167-8140(01)00404-2","volume":"61","author":"RJ Myerson","year":"2001","unstructured":"Myerson RJ, Kong F, Birnbaum EH et al (2001) Radiation therapy for epidermoid carcinoma of the anal canal, clinical and treatment factors associated with outcome. Radiother Oncol 61:15\u201322","journal-title":"Radiother Oncol"},{"key":"562_CR7","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1148\/radiographics.10.3.2188307","volume":"10","author":"A Scherrer","year":"1990","unstructured":"Scherrer A, Reboul F, Martin D, Dupuy JC, Menu Y (1990) CT of malignant anal canal tumours. Radiographics 10:433\u2013453","journal-title":"Radiographics"},{"key":"562_CR8","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.crad.2005.05.008","volume":"60","author":"SC Roach","year":"2005","unstructured":"Roach SC, Hulse PA, Moulding FJ, Wilson R, Carrington BM (2005) Magnetic resonance imaging of anal canal. Clin Radiol 60:1111\u20131119","journal-title":"Clin Radiol"},{"key":"562_CR9","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ijrobp.2008.08.070","volume":"74","author":"RJ Myerson","year":"2009","unstructured":"Myerson RJ, Garofalo MC, El Naqa I et al (2009) Elective clinical target volumes for conformal therapy in anorectal cancer: an radiation therapy oncology group consensus panel contouring atlas. Int J Radiat Oncol Biol Phys 74:824\u2013830","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"562_CR10","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1002\/cncr.25188","volume":"116","author":"JA Ajani","year":"2010","unstructured":"Ajani JA, Winter KA, Gunderson LL et al (2010) Prognostic factors derived from a prospective database dictate clinical biology of anal cancer. The intergroup trial (RTOG 98-11). Cancer 116:4007\u20134013","journal-title":"Cancer"},{"key":"562_CR11","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.ijrobp.2013.07.035","volume":"87","author":"LL Gunderson","year":"2013","unstructured":"Gunderson LL, Moughan J, Ajani JA et al (2013) RTOG 98-11. anal carcinoma: impact of TN category of disease on survival, disease relapse, and colostomy failure in US gastrointestinal intergroup RTOG 98-11 phase 3 trial. Int J Radiat Oncol Biol Phys 87:638\u2013645","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"562_CR12","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.ijrobp.2007.08.043","volume":"70","author":"MC Bassi","year":"2008","unstructured":"Bassi MC, Turri L, Sacchetti G et al (2008) FDG-PET\/CT imaging for staging and target volume delineation in preoperative conformal radiotherapy of rectal cancer. Int J Radiat Oncol Biol Phys 70:1423\u20131426","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"562_CR13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1748-717X-3-29","volume":"3","author":"L Deantonio","year":"2008","unstructured":"Deantonio L, Beldi D, Gambaro G et al (2008) FDG-PET\/CT imaging for staging and radiotherapy treatment planning of head and neck carcinoma. Radiat Oncol 3:29","journal-title":"Radiat Oncol"},{"key":"562_CR14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.clon.2012.08.007","volume":"25","author":"J Yoo","year":"2013","unstructured":"Yoo J, Henderson S, Walker-Dilks C (2013) Evidence-based guideline recommendations on the use of positron emission tomography imaging in head and neck cancer. Clin Oncol 25:33\u201366","journal-title":"Clin Oncol"},{"key":"562_CR15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11307-005-0003-6","volume":"7","author":"TG Trautmann","year":"2005","unstructured":"Trautmann TG, Zuger JH (2005) Positron emission tomography for pre-treatment staging and posttreatment evaluation in cancer of the anal canal. Mol Imaging Biol 7:309\u2013313","journal-title":"Mol Imaging Biol"},{"key":"562_CR16","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.ijrobp.2006.01.009","volume":"65","author":"SE Cotter","year":"2006","unstructured":"Cotter SE, Grigsby PW, Siegel BA et al (2006) PET\/CT in the evaluation of anal carcinoma. Int J Radiat Oncol Biol Phys 65:720\u2013725","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"562_CR17","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.radonc.2008.04.003","volume":"87","author":"BT Nguyen","year":"2008","unstructured":"Nguyen BT, Joon DL, Khoo V et al (2008) Assessing the impact of FDG-PET in the management of anal cancer. Radiother Oncol 87:376\u2013382","journal-title":"Radiother Oncol"},{"key":"562_CR18","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/sj.bjc.6604897","volume":"100","author":"E Winton","year":"2009","unstructured":"Winton E, Heriot AG, Ng M et al (2009) The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer. Br J Cancer 100:693\u2013700","journal-title":"Br J Cancer"},{"key":"562_CR19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1748-717X-5-10","volume":"5","author":"M Krengli","year":"2010","unstructured":"Krengli M, Milia ME, Turri L et al (2010) FDG-PET\/CT imaging for staging and target volume delineation in conformal radiotherapy of anal carcinoma. Radiat Oncol 5:10","journal-title":"Radiat Oncol"},{"key":"562_CR20","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/cncr.22974","volume":"110","author":"E Kidd","year":"2007","unstructured":"Kidd E, Siegel BA, Dehdashti F, Grigsby PW (2007) The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival. Cancer 110:1738\u20131744","journal-title":"Cancer"},{"key":"562_CR21","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/JTO.0b013e31815e6d6b","volume":"3","author":"T Berghmans","year":"2008","unstructured":"Berghmans T, Dusart M, Paesmans M et al (2008) Primary tumour SUVmax measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer: a systematic review and meta-analysis by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project. J Thorac Oncol 3:6\u201312","journal-title":"J Thorac Oncol"},{"key":"562_CR22","volume-title":"AJCC cancer staging manual","author":"SB Edge","year":"2010","unstructured":"Edge SB, Byrd DR, Compton CC et al (2010) AJCC cancer staging manual, 7th edn. Springer, New York","edition":"7"},{"key":"562_CR23","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228\u2013247","journal-title":"Eur J Cancer"},{"key":"562_CR24","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.radonc.2010.02.019","volume":"95","author":"EA Kidd","year":"2010","unstructured":"Kidd EA, Dehdashti F, Siegel BA, Grigsby PW (2010) Anal cancer maximum F-18 fluorodeoxyglucose uptake on positron emission tomography is correlated with prognosis. Radiother Oncol 95:288\u2013291","journal-title":"Radiother Oncol"},{"key":"562_CR25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2967\/jnumed.112.109470","volume":"54","author":"JG Bazan","year":"2013","unstructured":"Bazan JG, Koong AC, Kapp DS et al (2013) Metabolic tumour volume predicts disease progression and survival in patients with squamous cell carcinoma of the anal canal. J Nucl Med 54:27\u201332","journal-title":"J Nucl Med"},{"key":"562_CR26","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.ijrobp.2006.12.052","volume":"68","author":"P Das","year":"2007","unstructured":"Das P, Bhatia S, Eng C et al (2007) Predictors and patterns of recurrence after definitive chemoradiation for anal cancer. Int J Radiat Oncol Biol Phys 68:794\u2013800","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"562_CR27","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1200\/JCO.2012.43.8085","volume":"30","author":"LL Gunderson","year":"2012","unstructured":"Gunderson LL, Winter KA, Ajani JA et al (2012) Long-term update of US GI Intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil\/mitomycin versus fluorouracil\/cisplatin. J Clin Oncol 30:4344\u20134351","journal-title":"J Clin Oncol"},{"key":"562_CR28","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.athoracsur.2005.09.063","volume":"81","author":"N Rizk","year":"2006","unstructured":"Rizk N, Downey RJ, Akhurst T et al (2006) Preoperative 18 FDG-PET standardized uptake values predict survival after esophageal adenocarcinoma resection. Ann Thorac Surg 81:1076\u20131081","journal-title":"Ann Thorac Surg"},{"key":"562_CR29","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ijrobp.2007.04.036","volume":"69","author":"P Lee","year":"2007","unstructured":"Lee P, Weerasuriya DK, Lavori PW et al (2007) Metabolic tumour burden predicts for disease progression and death in lung cancer. Int J Radiat Oncol Biol Phys 69:328\u2013333","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"562_CR30","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ijrobp.2010.11.050","volume":"82","author":"A Higgins","year":"2012","unstructured":"Higgins A, Hoang JK, Roach M et al (2012) Analysis of pretreatment FDG-PET SUV parameters in head-and-neck cancer: tumour SUVmean has superior prognostic value. Int J Radiat Oncol Biol Phys 82:548\u2013553","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"562_CR31","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cllc.2011.05.001","volume":"13","author":"P Lee","year":"2012","unstructured":"Lee P, Bazan JG, Lavori PW et al (2012) Metabolic tumour volume is an independent prognostic factor in patients treated definitively for non-small-cell lung cancer. Clin Lung Cancer 13:52\u201358","journal-title":"Clin Lung Cancer"},{"key":"562_CR32","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.ijrobp.2011.10.023","volume":"83","author":"C Tang","year":"2012","unstructured":"Tang C, Murphy JD, Khong B et al (2012) Validation that metabolic tumour volume predicts outcome in head-and-neck cancer. Int J Radiat Oncol Biol Phys 83:1514\u20131520","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"562_CR33","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ijrobp.2007.09.005","volume":"71","author":"JK Schwarz","year":"2008","unstructured":"Schwarz JK, Siegel BA, Dehdashti F et al (2008) Tumor response and survival predicted by post-therapy FDG-PET\/CT in anal cancer. Int J Radiat Oncol Biol Phys 71:180\u2013186","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["La radiologia medica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-015-0562-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11547-015-0562-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-015-0562-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T12:33:09Z","timestamp":1559392389000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11547-015-0562-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["562"],"URL":"https:\/\/doi.org\/10.1007\/s11547-015-0562-9","relation":{},"ISSN":["0033-8362","1826-6983"],"issn-type":[{"value":"0033-8362","type":"print"},{"value":"1826-6983","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,1]]}}}